Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






World News World Health Organization Rejects Antiviral Drug Remdesivir As Covid 19 Treatment The New York Times

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, World News World Health Organization Rejects Antiviral Drug Remdesivir As Covid 19 Treatment The New York Times is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


World News World Health Organization Rejects Antiviral Drug Remdesivir As Covid 19 Treatment The New York Times | RobinsPost News & Noticias

EU says no change to uses of Gilead's remdesivir after WHO guidance


The European Commission on Friday said there had been no change in the authorised uses of Gilead's remdesivir after the World Health Organization advised against using the antiviral for treating ... Read More

EU drugs regulator endorses changes to remdesivir marketing for COVID-19 use


Dec 11 (Reuters) - Europe's drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a COVID-19 treatment, to make clear the ... Read More

U.S. infectious disease group backs Gilead's remdesivir for COVID-19 treatment


The top U.S. infectious disease medical association said on Monday that Gilead Sciences Inc's antiviral drug remdesivir should be used for hospitalized COVID-19 patients despite a World Health ... Read More

European countries face shortages of COVID-19 drug remdesivir


European countries are facing shortages of COVID-19 drug remdesivir because limited supplies are running out, officials said, with cases surging and the United States having bought up most of ... Read More

Gilead shares rise after United States approves remdesivir as COVID-19 drug


Oct 23 (Reuters) - Shares of Gilead Sciences Inc (GILD.O), opens new tab rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus